Medilifestyle (Catalyst: Z4D) 2023 full year results
Main financial results
-
Revenue: 1.94 million ringgit (down 19% from FY2022).
-
Net loss: 7.2 million ringgit (67% loss increase compared to FY2022).
-
loss of RM0.083 per share (worse than loss of RM0.075 in FY22).
All numbers shown in the chart above are for the trailing 12 month (TTM) period.
Medilifestyle’s stock price is up 18% from the previous week.
risk analysis
Before you take the next step, you need to know the following: 7 Warning Signs of a Medi Lifestyle What we discovered.
Have feedback on this article? Curious about its content? contact Please contact us directly. Alternatively, email our editorial team at Simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
